A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
about
Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapyComparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumorsDevelopment of "imageable" beads for transcatheter embolotherapy.Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolizationFour-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor modelPerfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinomaChemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinomaQuantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization.Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomesInter- and intra-rater agreement in the assessment of the vascularity of spinal metastases using digital subtraction angiography tumor blush.Four-dimensional transcatheter intraarterial perfusion (TRIP)-MRI for monitoring liver tumor embolization in VX2 rabbitsFour-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.Objective Measurement of Arterial Flow Before and After Transcatheter Arterial Chemoembolization: A Feasibility Study Using Quantitative Color-Coding Analysis.Quantitative assessment of angiographic perfusion reduction using color-coded digital subtraction angiography during transarterial chemoembolization.Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma.Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis.
P2860
Q27015918-BC36D53F-78F0-49DC-9D43-AB48D9AF2E53Q33376925-968F58CD-AD8D-4015-9C53-9F83716AFFC6Q33876358-EABE02AB-F213-4B91-B109-DE8EBC6986C1Q33911988-AD290B28-679F-414C-82E8-844175869A64Q33960387-2D008918-D77E-4158-824D-387B6E0E7ACEQ33998940-B5DB237C-F2B1-4FEC-A19B-F2951AE991E8Q34681150-B411E76E-8ACB-43B9-9F51-D8BE2809F3B2Q35168279-AF111575-98BA-451E-BF4F-286697B51222Q35203257-BB905D9B-28F4-4615-86F4-3FBAB2ACC22FQ35452809-23CC43CC-7747-4717-A933-B3D02C5BC0B6Q35988578-EDFA6CFF-982C-468A-93C9-340FE3F41BB1Q36421800-28B66EA8-E1E1-4245-BCE0-3DB43D1AE074Q37669068-6F95F77A-FE27-4573-8E42-B6A392248A85Q39369846-4B0DB314-E460-4A72-81E4-16921C06F77EQ39935859-60E24C66-6740-48D0-AACC-7C725C15A37EQ40042692-D8CD4CEA-BD1D-4F1C-8746-43E9D7479D03Q40279283-020CF7F3-D99C-4B3C-902D-A5130D07D617Q40363852-21ABCB9B-40DC-4EFB-8813-AEAD8270F82FQ40499216-AEC22260-1954-4A4C-A291-F6BFAD07E825Q41235807-147BF414-1B96-4557-84EF-742F0D4874F8Q53042583-EC65FA41-057C-4D74-8829-8A5AD212D81A
P2860
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@en
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@nl
type
label
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@en
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@nl
prefLabel
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@en
A comparison of chemoembolizat ...... rfusion/MR imaging monitoring.
@nl
P2093
P1476
A comparison of chemoembolizat ...... erfusion/MR imaging monitoring
@en
P2093
Albert A Nemcek
Andrew C Larson
Bassel Atassi
Dingxin Wang
Frank H Miller
James Gehl
Laura Kulik
Mary F Mulcahy
Reed A Omary
P304
P356
10.1016/J.JVIR.2007.06.028
P50
P577
2007-10-01T00:00:00Z